Contineum Therapeutics, Inc.
CTNM
$4.95
$0.337.14%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.57M | -10.27M | -9.01M | -8.42M | -7.77M |
| Total Depreciation and Amortization | 75.00K | 62.00K | 60.00K | 61.00K | 37.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.34M | 1.72M | 659.00K | 106.00K | -182.00K |
| Change in Net Operating Assets | 2.95M | 2.32M | -209.00K | 275.00K | -2.79M |
| Cash from Operations | -10.20M | -6.17M | -8.50M | -7.98M | -10.70M |
| Capital Expenditure | -166.00K | -82.00K | -119.00K | -147.00K | -309.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 20.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.22M | -30.12M | -38.78M | 8.88M | 9.34M |
| Cash from Investing | -9.39M | -30.18M | -38.90M | 8.73M | 9.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 642.00K | 13.00K | 108.22M | 122.00K | 50.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -28.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 140.00K | -140.00K | -343.00K |
| Cash from Financing | 642.00K | 13.00K | 108.36M | -18.00K | -321.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.95M | -36.34M | 60.97M | 738.00K | -2.00M |